Missouri Trust & Investment Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Missouri Trust & Investment Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$334K	Buy	2,275 +150	+7%	+$20.3K	0.09%	118
2026 Q1	$271K	Buy	2,125 +750	+55%	+$93.6K	0.08%	123
2025 Q4	$168K	Buy	1,375 +100	+8%	+$11.5K	0.05%	144
2025 Q3	$128K	Sell	1,275 -50	-4%	-$4.5K	0.04%	156
2025 Q2	$110K	Hold	1,325	–	–	0.04%	155
2025 Q1	$107K	Sell	1,325 -100	-7%	-$8.94K	0.04%	154
2024 Q4	$128K	Sell	1,425 -200	-12%	-$19.4K	0.05%	143
2024 Q3	$161K	Sell	1,625 -50	-3%	-$4.91K	0.06%	137
2024 Q2	$155K	Sell	1,675 -50	-3%	-$4.48K	0.06%	133
2024 Q1	$164K	Buy	1,725 +1,325	+331%	+$123K	0.06%	133
2023 Q4	$35.7K	Hold	400	–	–	0.01%	225
2023 Q3	$29.2K	Hold	400	–	–	0.01%	228
2023 Q2	$33.3K	Hold	400	–	–	0.02%	222
2023 Q1	$30.5K	Sell	400 -100	-20%	-$8.3K	0.02%	198
2022 Q4	$42K	Hold	500	–	–	0.03%	183
2022 Q3	$40K	Hold	500	–	–	0.03%	186
2022 Q2	$37K	Hold	500	–	–	0.02%	194
2022 Q1	$45K	Hold	500	–	–	0.03%	189
2021 Q4	$56K	Buy	+500	New	+$60.3K	0.03%	185

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Missouri Trust & Investment Company's XBI Position: Q2 2026 in Review

Missouri Trust & Investment Company increased its State Street SPDR S&P Biotech ETF (XBI) stake by 7.1% in Q2 2026, buying an estimated $20.3K and bringing the position to 2,275 shares worth $334K. The position accounts for 0.09% of the portfolio, ranked #118.

Missouri Trust & Investment Company first reported a position in XBI in Q4 2021 and has held it in 19 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Missouri Trust & Investment Company held 2,275 shares of State Street SPDR S&P Biotech ETF worth $334K as of Q2 2026.
Missouri Trust & Investment Company bought 150 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $20.3K.
State Street SPDR S&P Biotech ETF made up 0.09% of Missouri Trust & Investment Company's portfolio in Q2 2026, its #118 holding.
Missouri Trust & Investment Company first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 19 quarters since.
932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q2 2026, filed 13 Aug 2026.